These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30568037)

  • 1. Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells.
    Nguyen H; Kuril S; Bastian D; Kim J; Zhang M; Vaena SG; Dany M; Dai M; Heinrichs JL; Daenthanasanmak A; Iamsawat S; Schutt S; Fu J; Wu Y; Fairlie DP; Atkinson C; Ogretmen B; Tomlinson S; Yu XZ
    JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.
    Cravedi P; Leventhal J; Lakhani P; Ward SC; Donovan MJ; Heeger PS
    Am J Transplant; 2013 Oct; 13(10):2530-9. PubMed ID: 24033923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-presenting cell-derived complement modulates graft-versus-host disease.
    Kwan WH; Hashimoto D; Paz-Artal E; Ostrow K; Greter M; Raedler H; Medof ME; Merad M; Heeger PS
    J Clin Invest; 2012 Jun; 122(6):2234-8. PubMed ID: 22585573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
    Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease.
    Nguyen H; Alawieh A; Bastian D; Kuril S; Dai M; Daenthanasanmak A; Zhang M; Iamsawat S; Schutt SD; Wu Y; Sleiman MM; Shetty A; Atkinson C; Sun S; Varela JC; Tomlinson S; Yu XZ
    Clin Cancer Res; 2020 Jul; 26(13):3481-3490. PubMed ID: 31919135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.
    Kwan WH; van der Touw W; Paz-Artal E; Li MO; Heeger PS
    J Exp Med; 2013 Feb; 210(2):257-68. PubMed ID: 23382542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of Complement C3a and C5a Receptors Prevents Angiotensin II-Induced Hypertension via Regulatory T Cells.
    Chen XH; Ruan CC; Ge Q; Ma Y; Xu JZ; Zhang ZB; Lin JR; Chen DR; Zhu DL; Gao PJ
    Circ Res; 2018 Mar; 122(7):970-983. PubMed ID: 29437833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.
    Li N; Chen Y; He W; Yi T; Zhao D; Zhang C; Lin CL; Todorov I; Kandeel F; Forman S; Zeng D
    Blood; 2009 Jan; 113(4):953-62. PubMed ID: 18922852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.
    Strainic MG; Shevach EM; An F; Lin F; Medof ME
    Nat Immunol; 2013 Feb; 14(2):162-71. PubMed ID: 23263555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.
    Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.
    Lu Y; Giver CR; Sharma A; Li JM; Darlak KA; Owens LM; Roback JD; Galipeau J; Waller EK
    Blood; 2012 Jan; 119(4):1075-85. PubMed ID: 22130799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
    Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
    Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
    Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
    J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells.
    van der Touw W; Cravedi P; Kwan WH; Paz-Artal E; Merad M; Heeger PS
    J Immunol; 2013 Jun; 190(12):5921-5. PubMed ID: 23690475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg.
    Wang Y; Lai P; Chen X; He C; Huang X; Geng S; Luo C; Wu S; Ling W; Zhong L; Lu Z; Li P; Weng J; Du X
    Sci Rep; 2017 Jun; 7(1):3603. PubMed ID: 28620195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell function in allostimulation is modulated by C5aR signaling.
    Peng Q; Li K; Wang N; Li Q; Asgari E; Lu B; Woodruff TM; Sacks SH; Zhou W
    J Immunol; 2009 Nov; 183(10):6058-68. PubMed ID: 19864610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Effect of MyD88 Signal in Donor T Cells on Graft-versus-Leukemia Effect and Graft-versus-Host Disease after Experimental Allogeneic Stem Cell Transplantation.
    Lim JY; Ryu DB; Lee SE; Park G; Choi EY; Min CK
    Mol Cells; 2015 Nov; 38(11):966-74. PubMed ID: 26552489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
    Li JM; Giver CR; Lu Y; Hossain MS; Akhtari M; Waller EK
    Immunotherapy; 2009 Jul; 1(4):599-621. PubMed ID: 20191089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD.
    Lin KL; Fulton LM; Berginski M; West ML; Taylor NA; Moran TP; Coghill JM; Blazar BR; Bear JE; Serody JS
    Blood; 2014 Mar; 123(10):1604-14. PubMed ID: 24415540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.